| T6057 |
URMC-099
|
1229582-33-5
|
98%
|
|
|
URMC-099 is an orally bioavailable, brain penetrant MLK inhibitor (IC50: 19/42/14/150 nM, for MLK1/MLK2/MLK3/DLK), and also inhibits LRRK2 activity (IC50: 11 nM)...
|
| T9977 |
SGK1-IN-4
|
1628048-93-0
|
98%
|
|
|
SGK1-IN-4 is a selective inhibitor of SGK1 and can be used in studies about osteoarthritis.
|
| T19913 |
CKI-7
|
1177141-67-1
|
100.00%
|
|
|
CKI-7 is a potent and ATP-competitive inhibitor of casein kinase 1 (CK1; IC50: 6 μM; Ki: 8.5 μM) and a selective Cdc7 kinase inhibitor. CKI-7 also inhibits SGK, ...
|
| T6635 |
EMD638683
|
1181770-72-8
|
98%
|
|
|
EMD638683,a novel SGK inhibitor with antihypertensive potency(with an IC50 of 3 μM).
|
| T2356 |
Ro-3306
|
872573-93-8
|
98.59%
|
|
|
RO-3306 is a selectivity ATP-competitive CDK1 inhibitor (Ki: 20 nM). The selectivity of RO-3306 for CDK1 is >15-fold higher than a diverse panel of human kinases...
|
| T9589 |
SI-113
|
1392816-46-4
|
98.81%
|
|
|
SI-113 is a potent and selective inhibitor of SGK1, a serine/threonine protein kinase, that modulates several oncogenic signaling cascades.
|
| T2622 |
GSK 650394
|
890842-28-1
|
98.93%
|
|
|
GSK 650394 is a serum- and glucocorticoid-regulated kinase-1 inhibitor.
|
| T2482 |
AT13148
|
1056901-62-2
|
99%
|
|
|
AT13148 is an oral-active and ATP-competitive, multi-AGC kinase inhibitor for Akt1/2/3, p70S6K, PKA, and ROCKI/II.
|
| T14779 |
BRD7389
|
376382-11-5
|
99.17%
|
|
|
BRD7389 is an inhibitor of RSK family kinase with IC50s of 1.5 μM, 2.4 μM, and 1.2 μM for RSK1, RSK2, and RSK3, respectively.
|
| T11181 |
EMD638683 R-Form
|
1184940-47-3
|
98%
|
|
|
EMD638683 is a highly selective SGK1 inhibitor with IC50 of 3 μM. EMD638683 R-Form is the R-form of EMD638683.
|
